Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Amarin Corp Ads (AMRN)

Amarin Corp Ads (AMRN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Biotech Brief: Latest Electrophysiology Devices Vastly Improving Diagnosis and Treatment of Cardiovascular Diseases

According to a recent market research report published by Grand View Research, a consulting and advisory service firm that provides comprehensive, research-based views crucial for building business intelligence...

BHVN : 46.89 (-1.70%)
AIMT : 22.66 (+0.71%)
AMRN : 16.84 (-0.59%)
BSGM : 8.27 (+2.48%)
New 2019 Updates to the European Society of Cardiology's and European Atherosclerosis Society's Guidelines for the Management of Dyslipidaemias Incorporate Findings from the REDUCE-IT(TM) Cardiovascular Outcomes Study

Amarin Corporation plc (NASDAQ: AMRN), a pharmaceutical company focused on improving cardiovascular health, today announced that the European Society of Cardiology (ESC) and the European Atherosclerosis...

AMRN : 16.84 (-0.59%)
Amarin to Participate in the H.C. Wainwright 21st Annual Global Investment Conference

Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F. Thero, Amarin's...

AMRN : 16.84 (-0.59%)
Amarin to Participate in a Fireside Chat at Citi's 14th Annual Biotech Conference

Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F. Thero, Amarin's...

AMRN : 16.84 (-0.59%)
Biotech Stock Roundup: Amgen's Enbrel Patent Win, AMRN's Setback & More

Key highlights of the past week include collaborations, and other regulatory and pipeline news.

AMRN : 16.84 (-0.59%)
ALNY : 86.50 (+2.25%)
GILD : 66.42 (+0.70%)
REGN : 295.87 (+3.40%)
AMGN : 196.94 (+0.66%)
Non-Invasive Cellulite Treatments and Devices Dominating Billion Dollar Market

People with cellulite are not as happy as those without cellulite. That may seem to be self-evident, but now it is supported by studies. One such report, a study published by Surgical and Cosmetic Dermatology,...

AMRN : 16.84 (-0.59%)
DCPH : 36.53 (+1.42%)
LLY : 116.16 (+1.58%)
GILD : 66.42 (+0.70%)
SOLY : 13.33 (-2.06%)
Amarin (AMRN) Alert: Johnson Fistel Launches Investigation into Amarin Corporation plc; Investors Encouraged to Contact Firm

Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against Amarin Corporation plc ("Amarin") (NASDAQ: AMRN) for violations of federal securities laws.

AMRN : 16.84 (-0.59%)
Amarin (AMRN) Beats Earnings & Beats Revenues in Q2

Amarin beats estimates for both earnings and revenues in the second quarter of 2019. Shares up.

AMRN : 16.84 (-0.59%)
Amarin Announces Underwriters' Full Exercise of Option to Purchase Additional American Depositary Shares

Amarin Corporation plc (NASDAQ:AMRN) today announced that, in connection with its previously announced underwritten public offering of American Depositary Shares ("ADSs"), the underwriters of the offering...

AMRN : 16.84 (-0.59%)
What's in the Cards for Amarin (AMRN) This Earnings Season?

Amarin's (AMRN) cardiovascular drug, Vascepa is expected to drive sales in the second quarter.

AMRN : 16.84 (-0.59%)
AGN : 166.47 (+0.45%)
GILD : 66.42 (+0.70%)
REGN : 295.87 (+3.40%)
Amarin to Report Second Quarter 2019 Results and Host Conference Call on July 31, 2019

Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, today announced that it will host a conference call with members of Amarin senior management to...

AMRN : 16.84 (-0.59%)
Amarin Prices Public Offering of American Depositary Shares

Amarin Corporation plc (NASDAQ: AMRN) today announced the pricing of the underwritten public offering of 22,222,223 American Depositary Shares ("ADSs") at a price to the public of $18.00 per ADS. The gross...

AMRN : 16.84 (-0.59%)
Amarin Announces $400,000,000 Public Offering of American Depositary Shares

Amarin Corporation plc (NASDAQ: AMRN) today announced that it has commenced an underwritten public offering of $400,000,000 of its American Depositary Shares pursuant to a shelf registration. All of the...

AMRN : 16.84 (-0.59%)
Biotech Brief: Researchers Looking at New Bundled Treatment Options for Leukemia

The American Cancer Society estimates that in 2019 there will be about 61,780 new cases of leukemia and 22,840 deaths from leukemia and 21,450 new cases of acute myeloid leukemia (AML). Most will be in...

ENDP : 3.48 (+3.57%)
AMRN : 16.84 (-0.59%)
ALT : 2.11 (+3.43%)
TEVA : 7.45 (-1.06%)
MBRX : 1.12 (-3.45%)
Implied Volatility Surging for Amarin (AMRN) Stock Options

Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately.

AMRN : 16.84 (-0.59%)
Amarin (AMRN) Issues Update on Q2 Sales, Raises '19 Guidance

Amarin announces strong preliminary sales of Vascepa in the second quarter. The company increases sales guidance for 2019.

AMRN : 16.84 (-0.59%)
BDSI : 4.60 (-1.92%)
AMGN : 196.94 (+0.66%)
SNY : 46.46 (+3.43%)
Company News for Jul 3, 2019

Companies In The News Are: DAL, AMRN, HRS, ADP

AMRN : 16.84 (-0.59%)
HRS : 189.13 (-0.17%)
ADP : 159.30 (-0.03%)
DAL : 58.63 (-0.10%)
Thinking about trading options or stock in Apple, Amarin, BP, Cisco Systems, or Morgan Stanley?

InvestorsObserver issues critical PriceWatch Alerts for AAPL, AMRN, BP, CSCO, and MS.

AAPL : 217.73 (-1.46%)
CSCO : 49.60 (+0.83%)
AMRN : 16.84 (-0.59%)
MS : 43.67 (-0.80%)
BP : 38.99 (+0.78%)
Amarin's John Thero Awarded NJ EY Entrepreneur of The Year(R) 2019 Award for Life Sciences

Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F. Thero, president...

AMRN : 16.84 (-0.59%)
CORRECTING and REPLACING -- Amarin to Present Findings Regarding Challenges of Current Treatment Options in Reducing Cardiovascular Risks for Diabetes Patients, Even for Those With Controlled Cholesterol Levels, at Annual American Diabetes Association (ADA) Meeting

Approximately 10 Million People with Diabetes Are at Elevated Risk of Cardiovascular Disease

AMRN : 16.84 (-0.59%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
AIZ +0.41 , WELL -0.50 , SBAC +5.56 , CCI -0.66 , SO +0.05
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar